Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Neurology|October 27, 2023
Magnetic resonance imaging arterial spin labeling hypoperfusion with diffusion-weighted image hyperintensity is useful for diagnostic imaging of Creutzfeldt-Jakob diseaseYuki Kitazaki, Masamichi Ikawa, Tadanori Hamano, et al.
Frontiers in Neurology|January 19, 2024
Case report: Clinically mild encephalitis/encephalopathy with a reversible splenial lesion: an autopsy caseMaho Hayashi, Midori Ueda, Koji Hayashi, et al.
Frontiers in Medicine|March 26, 2025
Case Report: Bilateral adrenal hemorrhage and hemophagocytosis in the reticuloendothelial system caused by Escherichia coli in a young woman: an autopsy caseYudai Tanaka, Koji Hayashi, Ei Kawahara, et al.
Nutrients|October 17, 2020
Influences of Folate Supplementation on Homocysteine and Cognition in Patients with Folate Deficiency and Cognitive ImpairmentYuka Hama, Tadanori Hamano, Norimichi Shirafuji, et al.
International Journal of Molecular Sciences|November 13, 2021
Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau ProteinGaoping Lin, Feiyan Zhu, Nicholas M Kanaan, et al.
Frontiers in Aging Neuroscience|January 23, 2023
Effectiveness of a self-reporting yes/no survey for dementia screening-trial in Fukui, JapanTadanori Hamano, Miwako Nagata, Rokuro Matsubara, et al.
Surgery Today|April 15, 2022
Decreased numbers of gastric, colorectal, lung, and breast cancer surgeries performed in 17 cancer-designated hospitals in Gunma Prefecture of Japan during the COVID-19 pandemicHiroshi Saeki, Ken Shirabe, Tatsuya Miyazaki, et al.
Anticancer Research|July 27, 2022
Salvage PTBD With Chemotherapy Improves Survival in Patients With Unresectable Malignant Biliary Obstruction - A Single Center Retrospective StudyDaisuke Muroya, Hirotoshi Tsuru, Hisaaki Shimokobe, et al.
Stroke|January 26, 2017
YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy)Junya Aoki, Kazumi Kimura, Naomi Morita, et al.
Frontiers in Pharmacology|October 31, 2022
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's diseaseMosaburo Kainuma, Shinji Ouma, Shinobu Kawakatsu, et al.
Pageof 6